Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

WSR Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$20M
Portfolio companies 1
Lead investments 0
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Biopharma
  • Health Care
  • Biotechnology
  • Pharmaceutical
Summary

The company was established in North America in United States. The main department of described VC is located in the Highlands Ranch.

The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2013. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The overall number of key employees were 1.

Among the most popular portfolio startups of the fund, we may highlight Apexigen. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Health Care, Biopharma.

The standard case for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Themes Investment Partners, Sycamore Ventures, China Development Industrial Bank (CDIB). In the next rounds fund is usually obtained by Virtus Inspire Ventures, SV Tech Ventures, Decheng Capital.

Read more

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Calyx Bio-Ventures British Columbia, Canada, Vancouver
Capital6 Eagle -
First In Ventures -
First Seafront Fund China, Guangdong, Shenzhen
Hengjin Touzi -
Hongfu Ruiying China, Guangdong, Shenzhen
INROADS Capital Partners Evanston, Illinois, United States
Mitacs British Columbia, Canada, Vancouver
Moonwhale Ventures Delaware, Ohio, United States
Morgan Stanley Capital Partners New York, New York, United States
NLINKS Japan, Tokyo
OLMA Private Equity Fund County Dublin, Dublin, Ireland
PALgenesis New York, New York, United States
PlayFast Games -
Rich Land Capital Beijing, Beijing, China
Rongta Ziben China, Guangxi, Jiangsu
SCP Vitalife Partners Pennsylvania, United States, Wayne
Serena Ventures California, San Francisco, United States
Transformation Capital Boston, Massachusetts, United States
Zencoder California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Apexigen

Biopharma
Biotechnology
Health Care
Pharmaceutical
$20M06 Aug 2013 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent WSR Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 20M
Peak activity year 2013
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Apexigen

Biopharma
Biotechnology
Health Care
Pharmaceutical
$20M06 Aug 2013 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: